bioLytical™ Laboratories Receives Licensing Approval for INSTI(TM) Kit in Latin America
VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Aug 7, 2007 -- bioLytical Laboratories (bioLytical) announced today that it has received final licensing approval for the INSTI(TM) kit in Venezuela and Mexico. INSTI(TM), a 60-second rapid HIV test for point-of-care testing, is now available in these countries for sale and distribution.